Docket #: S03-157A
Anti-MLL.N Monoclonal Antibody
Monoclonal antibody that recognizes MLL, an oncoprotein that is mutated in a broad subset of pediatric and adult leukemias. MLL protein displays histone methyltransferase activity.
Advantages
- Improved monoclonal antibody directed against the protein. Useful for biochemical studies of ML1.
Similar Technologies
-
Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7 S83-007Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7
-
Expansion of Human iPSC-derived Cardiomyocytes In Vitro Through Small Molecule Inhibition of Cell-Cell Contact S20-273Expansion of Human iPSC-derived Cardiomyocytes In Vitro Through Small Molecule Inhibition of Cell-Cell Contact
-
NF-AT transcription system for screening of immunosuppressive drugs•The Fgl-5 cell line S91-041NF-AT transcription system for screening of immunosuppressive drugs•The Fgl-5 cell line